Targeting mucosal dendritic cells with microbial antigens from probiotic lactic acid bacteria (Q37103921)

18 August 2017

1 reference

title

Targeting mucosal dendritic cells with microbial antigens from probiotic lactic acid bacteria (English)

1 reference

18 August 2017

0 references

0 references

1 reference

4

Todd R Klaenhammer

1 reference

18 August 2017

Mansour Mohamadzadeh

1

1 reference

18 August 2017

Tri Duong

series ordinal

2

1 reference

18 August 2017

Timothy Hoover

series ordinal

3

1 reference

18 August 2017

language of work or name

1 reference

1 March 2008

1 reference

Expert Review of Vaccines

18 August 2017

1 reference

18 August 2017

7

1 reference

18 August 2017

2

1 reference

18 August 2017

163-174

1 reference

Microbial-gut interactions in health and disease. Mucosal immune responses

18 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

New trends in antigen uptake in the gut mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Mucosal immunity and vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Toll-like receptors: critical proteins linking innate and acquired immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

'Toll' gates for future immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Toll-like receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Flagellin stimulation of intestinal epithelial cells triggers CCL20-mediated migration of dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

The yin and yang of intestinal epithelial cells in controlling dendritic cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

The role of M cells in mucosal immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Epithelial M cells: differentiation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Collaboration of epithelial cells with organized mucosal lymphoid tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

21 January 2018

Much ado about M cells

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Formation of Peyer's patches

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

M cells at locations outside the gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

The development of M cells in Peyer's patches is restricted to specialized dome-associated crypts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Antigen transport into Peyer's patches: increased uptake by constant numbers of M cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Plasticity of the gastrointestinal epithelium: the M cell paradigm and opportunism of pathogenic microorganisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Expression and distribution of beta1 integrins in in vitro-induced M cells: implications for Yersinia adhesion to Peyer's patch epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Intestinal villous M cells: an antigen entry site in the mucosal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Taking dendritic cells into medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Immunobiology of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

How dendritic cells and microbes interact to elicit or subvert protective immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Sensing pathogens and tuning immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Development of dendritic-cell lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

New insights into the mobilization and phagocytic activity of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Regulation of T cell immunity by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Freshly isolated mouse 4F7+ splenic dendritic cells process and present exogenous antigens to T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Interleukin 15 skews monocyte differentiation into dendritic cells with features of Langerhans cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Sites of B-cell activation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

A form of immunologic tolerance through impairment of germinal center development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Distinct populations of dendritic cells are present in the subepithelial dome and T cell regions of the murine Peyer's patch

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Immunology. Keeping the gut microflora at bay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Regulation of IgA production by naturally occurring TNF/iNOS-producing dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Generation of gut-homing T cells and their localization to the small intestinal mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Functional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective T cell homing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Oral tolerance: is it all retinoic acid?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Bacteria as DNA vaccine carriers for genetic immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

How Ebola and Marburg viruses battle the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Chimeric recombinant hepatitis E virus-like particles as an oral vaccine vehicle presenting foreign epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Papillomavirus pseudovirus: a novel vaccine to induce mucosal and systemic cytotoxic T-lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Filovirus-like particles as vaccines and discovery tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Status and challenges of filovirus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Modulation of the immune response by the cholera-like enterotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Oral cavity as natural reservoir for intestinal lactobacilli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Probiotics: an overview of beneficial effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Comparison of abilities of Salmonella enterica serovar typhimurium aroA aroD and aroA htrA mutants to act as live vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Use of Bordetella bronchiseptica and Bordetella pertussis as live vaccines and vectors for heterologous antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Enteral immunization with attenuated recombinant Listeria monocytogenes as a live vaccine vector: organ-dependent dynamics of CD4 T lymphocytes reactive to a Leishmania major tracer epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Lactic acid bacteria as antigen delivery vehicles for oral immunization purposes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Lactic acid bacteria as vaccine delivery vehicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Potential and opportunities for use of recombinant lactic acid bacteria in human health

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Instruments for oral disease-intervention strategies: recombinant Lactobacillus casei expressing tetanus toxin fragment C for vaccination or myelin proteins for oral tolerance induction in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Probiotics as biotherapeutic agents: present knowledge and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Stimulation of cytokine production in clonal macrophage and T-cell models by Streptococcus thermophilus: comparison with Bifidobacterium sp. and Lactobacillus bulgaricus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Peptides identified through phage display direct immunogenic antigen to dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Expression of the protective antigen of Bacillus anthracis by Lactobacillus casei: towards the development of an oral vaccine against anthrax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Oral administration of human papillomavirus type 16 E7 displayed on Lactobacillus casei induces E7-specific antitumor effects in C57/BL6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Intragastric immunization with recombinant Lactobacillus casei expressing flagellar antigen confers antibody-independent protective immunity against Salmonella enterica serovar Enteritidis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Expression of Streptococcus pneumoniae antigens, PsaA (pneumococcal surface antigen A) and PspA (pneumococcal surface protein A) by Lactobacillus casei.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Mucosal immunization with surface-displayed severe acute respiratory syndrome coronavirus spike protein on Lactobacillus casei induces neutralizing antibodies in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Oral immunization of mice with lactic acid bacteria producing Helicobacter pylori urease B subunit partially protects against challenge with Helicobacter felis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Protective immunity of SpaA-antigen producing Lactococcus lactis against Erysipelothrix rhusiopathiae infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunisations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.2.163

21 January 2018

Identifiers

DOI

10.1586/14760584.7.2.163

1 reference

18 August 2017

1 reference